Last reviewed · How we verify
Sequential TACE and SBRT Followed by ImmunoTherapy for Downstaging HCC for Hepatectomy (START-FIT)
This study is a prospective phase II, single arm clinical study conducted in Queen Mary Hospital (Hong Kong) assessing the efficacy and safety of the sequential administration of trans-arterial chemo-embolization (TACE) and stereotactic body radiotherapy (SBRT) with an immune checkpoint inhibitor in hepatocellular carcinoma (HCC) patients.
Details
| Lead sponsor | The University of Hong Kong |
|---|---|
| Phase | PHASE2 |
| Status | COMPLETED |
| Enrolment | 33 |
| Start date | Fri Mar 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Wed Jul 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- HCC
Interventions
- TACE
- SBRT
- Immune Checkpoint Inhibitor
Countries
Hong Kong